Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
0.907
+0.007 (0.72%)
At close: Nov 22, 2024, 4:00 PM
0.910
+0.003 (0.29%)
After-hours: Nov 22, 2024, 7:45 PM EST

Ocugen Statistics

Total Valuation

Ocugen has a market cap or net worth of $264.34 million. The enterprise value is $232.43 million.

Market Cap 264.34M
Enterprise Value 232.43M

Important Dates

The last earnings date was Friday, November 8, 2024, before market open.

Earnings Date Nov 8, 2024
Ex-Dividend Date n/a

Share Statistics

Ocugen has 291.32 million shares outstanding. The number of shares has increased by 11.56% in one year.

Current Share Class 291.32M
Shares Outstanding 291.32M
Shares Change (YoY) +11.56%
Shares Change (QoQ) +8.03%
Owned by Insiders (%) 1.36%
Owned by Institutions (%) 27.43%
Float 287.37M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 50.66
Forward PS n/a
PB Ratio 6.48
P/TBV Ratio 6.51
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 49.45
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.58, with a Debt / Equity ratio of 0.17.

Current Ratio 2.58
Quick Ratio 2.46
Debt / Equity 0.17
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -103.30% and return on invested capital (ROIC) is -58.38%.

Return on Equity (ROE) -103.30%
Return on Assets (ROA) -47.98%
Return on Capital (ROIC) -58.38%
Revenue Per Employee $72,308
Profits Per Employee -$786,831
Employee Count 65
Asset Turnover 0.07
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +134.47% in the last 52 weeks. The beta is 3.76, so Ocugen's price volatility has been higher than the market average.

Beta (5Y) 3.76
52-Week Price Change +134.47%
50-Day Moving Average 0.98
200-Day Moving Average 1.30
Relative Strength Index (RSI) 44.59
Average Volume (20 Days) 4,251,873

Short Selling Information

The latest short interest is 50.65 million, so 17.38% of the outstanding shares have been sold short.

Short Interest 50.65M
Short Previous Month 51.92M
Short % of Shares Out 17.38%
Short % of Float 17.62%
Short Ratio (days to cover) 16.43

Income Statement

In the last 12 months, Ocugen had revenue of $4.70 million and -$51.14 million in losses. Loss per share was -$0.20.

Revenue 4.70M
Gross Profit -26.92M
Operating Income -52.44M
Pretax Income -50.86M
Net Income -51.14M
EBITDA -50.89M
EBIT -52.44M
Loss Per Share -$0.20
Full Income Statement

Balance Sheet

The company has $38.70 million in cash and $6.78 million in debt, giving a net cash position of $31.91 million or $0.11 per share.

Cash & Cash Equivalents 38.70M
Total Debt 6.78M
Net Cash 31.91M
Net Cash Per Share $0.11
Equity (Book Value) 40.63M
Book Value Per Share 0.14
Working Capital 24.91M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$43.08 million and capital expenditures -$6.09 million, giving a free cash flow of -$49.17 million.

Operating Cash Flow -43.08M
Capital Expenditures -6.09M
Free Cash Flow -49.17M
FCF Per Share -$0.17
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -1,115.79%
Pretax Margin -1,088.17%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -664.95%

Dividends & Yields

Ocugen does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -11.56%
Shareholder Yield -11.56%
Earnings Yield -19.35%
FCF Yield -18.60%

Analyst Forecast

The average price target for Ocugen is $5.67, which is 524.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target $5.67
Price Target Difference 524.86%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) 87.51%
EPS Growth Forecast (5Y) -39.89%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Ocugen has an Altman Z-Score of -1.87 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.87
Piotroski F-Score 2